APPLICATION OF A NEW TYROSINKINASE INHIBITOR, ANLOTINIBA, IN OSTEOSARCOMA AND… N/A RU-2787235-C2 Russian Federation 30 Dec 2022
QUINOLINE DERIVATIVE FOR TREATMENT OF NEUROENDOCRINE TUMORS Application EP-3682883-A4 European Patent Office 02 Jun 2021
Quinoline derivative against non-small cell lung cancer Application US-10307412-B2 United States of America 04 Jun 2019